Then, two distinct siRNAs (siRNA1 and siRNA2) were used to silence P2X7 expression, and each siRNA achieved a prominent effect on knockdown of P2X7 in prostate cancer cells (Fig. 2B). Here, P2RX7 is linked to prostate carcinoma.